Journal of Gastroenterology and Hepatology · 2012 · 25 citations · 23 references
MedicinePharmacologyPharmacotherapyAnesthesiaClinical PharmacologyGastroenterologyDrug EvaluationGastrointestinal EndoscopySedation ProtocolsFlickerIntravenous Midazolam SedationMidazolam UsePropofol UsePsychometric PropertiesRandomized Controlled Trial BaselineSedation In Hepatic ImpairmentSedation Outcome Measurement
BACKGROUND AND AIM: People with cirrhosis are at increased risk of development of complications related to sedation. The aim of the present study was to compare the effects of sedation for upper gastrointestinal endoscopy (UGIE) with propofol and midazolam on psychometric tests and critical flicker frequency (CFF) in people with cirrhosis. METHODS: A total of 127 people with cirrhosis were randomized into three groups: propofol group (n = 40), midazolam group (n = 42) and no sedation (n = 45). All patients underwent CFF test and combination of psychometry (number connection test-A and B [NCT-A,B]; digit symbol test [DST], line tracing test [LTT] and serial dotting test [SDT]) at baseline and at 2 h post-endoscopy. CFF was done at 30 min and repeated every 30 min for 2 h. RESULTS: In the propofol group there was no deterioration in psychometry (NCT-A [55.6 ± 18.7 vs 56.4 ± 19.0 s], NCT-B [98.2 ± 35.1 vs 97.8 ± 34.6 s], DST [26.7 ± 5.7 vs 26.3 ± 5.3], LTT [112.9 ± 35.7 vs 113.7 ± 36.6 s], SDT [94.6 ± 34.1 vs 95.2 ± 34.5 s]). Significant deterioration from baseline (39.8 ± 2.9 Hz) was seen in CFF at 30 min (38.8 ± 2.3 Hz) and 1 h (39.2 ± 2.4 Hz), P = 0.01 but no difference thereafter. In the midazolam group, significant deterioration was observed on psychometry (NCT-A [56.0 ± 18.5 vs 60.4 ± 19.8 s], NCT-B [99.9 ± 29.1 vs 105.9.6 ± 30.3 s], DST [26.1 ± 4.7 vs 25.2 ± 4.3], LTT [129.1 ± 34.5 vs 132.9 ± 35.4 s], SDT [95.6 ± 34.2]). No deterioration was observed in psychometry and CFF in people with cirrhosis without sedation. CONCLUSIONS: Propofol sedation for UGIE was associated with earlier recovery compared with midazolam, which causes deterioration of psychometric tests and CFF for a longer time in comparison with propofol.
23
Péter Ferenci, Alan H. Lockwood, Kevin D. Mullen et al. · Hepatology · 2002 · 2K citations · Full text
Critical flicker frequency for quantification of low-grade hepatic encephalopathy
G. Kircheis, Matthias Wettstein, Lars Timmermann et al. · Hepatology · 2002 · 396 citations
Medicine, Neurology, Hepatology +16
Value of the critical flicker frequency in patients with minimal hepatic encephalopathy†
Manuel Romero‐Gómez, Juan Córdoba, Rodrigo Jover et al. · Hepatology · 2007 · 322 citations · Full text
Minimal Hepatic Encephalopathy Is Associated with Motor Vehicle Crashes
Jasmohan S. Bajaj, Kia Saeian, Christine M. Schubert et al. · Hepatology · 2009 · 321 citations · Full text
Hannu Allonen, G. Ziegler, Ulrich Klotz · Clinical Pharmacology & Therapeutics · 1981 · 288 citations